Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $2.30 in the prior trading day, Nuvation Bio Inc (NYSE: NUVB) closed at $2.21, down -3.91%. In other words, the price has decreased by -$3.91 from its previous closing price. On the day, 1.09 million shares were traded. NUVB stock price reached its highest trading level at $2.315 during the session, while it also had its lowest trading level at $2.2.
Ratios:
Our goal is to gain a better understanding of NUVB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.49 and its Current Ratio is at 11.49. In the meantime, Its Debt-to-Equity ratio is 1.13 whereas as Long-Term Debt/Eq ratio is at 1.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on March 27, 2024, Upgraded its rating to Buy and sets its target price to $10 from $1.40 previously.
On March 26, 2024, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $5.
Jefferies Downgraded its Buy to Hold on January 06, 2023, whereas the target price for the stock was revised from $5 to $2.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 08 ’24 when Mashal Robert bought 100,000 shares for $2.20 per share. The transaction valued at 220,000 led to the insider holds 100,000 shares of the business.
Cui Xiangmin bought 277,895 shares of NUVB for $825,348 on Jun 25 ’24. The Director now owns 2,453,131 shares after completing the transaction at $2.97 per share. On Jun 24 ’24, another insider, Cui Xiangmin, who serves as the Director of the company, bought 336,874 shares for $2.98 each. As a result, the insider paid 1,003,885 and bolstered with 2,175,236 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NUVB now has a Market Capitalization of 780037248 and an Enterprise Value of 263282736. For the stock, the TTM Price-to-Sale (P/S) ratio is 513.79 while its Price-to-Book (P/B) ratio in mrq is 2.14. Its current Enterprise Value per Revenue stands at 183.472 whereas that against EBITDA is -0.49.
Stock Price History:
Over the past 52 weeks, NUVB has reached a high of $4.16, while it has fallen to a 52-week low of $0.95. The 50-Day Moving Average of the stock is -16.94%, while the 200-Day Moving Average is calculated to be -17.81%.
Shares Statistics:
The stock has traded on average 1.50M shares per day over the past 3-months and 1182840 shares per day over the last 10 days, according to various share statistics. A total of 334.78M shares are outstanding, with a floating share count of 227.21M. Insiders hold about 32.13% of the company’s shares, while institutions hold 39.13% stake in the company. Shares short for NUVB as of 1728950400 were 9970011 with a Short Ratio of 6.66, compared to 1726185600 on 20234271. Therefore, it implies a Short% of Shares Outstanding of 9970011 and a Short% of Float of 4.19.
